How to appeal a Humana hereditary angioedema (hae) denial

The framework that applies to your appeal

Medicare Advantage plans follow a separate appeal track from commercial plans. Reconsideration must be requested within 60 days; if the plan misses its deadline, the case auto-forwards to the IRE (Maximus).

Humana-specific note: Heavily Medicare Advantage focused. MA-specific appeal track (42 CFR Part 422 Subpart M) applies — 60 days to request reconsideration, NOT the 180 days for commercial plans. Auto-forward to IRE (Maximus) if Humana misses deadline.

What Humana's policy requires for hereditary angioedema (hae)

Cited policy: Humana Home Self-Administration Training + Supplies for HAE

Patient or caregiver trained on self-injection (Haegarda SC, Berinert IV self-infuse, Firazyr SC). Documented competency. Home supply allotment matched to attack frequency + prophylaxis schedule.

How Humana denies hereditary angioedema (hae) — and how to counter it

Where Humana pushes back: 1) Home self-admin not covered; 2) Office/HCP administration only.

Counter-arguments that hold up: WAO/EAACI strongly recommends self-administration to minimize time-to-treat (<2 hr improves outcomes — Bork). Denial of home admin leads to ER reliance, higher cost, worse outcomes. US HAEA 2020 endorses self-administration training for all eligible patients. Document competency completion + action plan.

What Humana typically denies for hereditary angioedema (hae)

Across Humana's commercial and Medicare books, denials cluster around a small number of patterns. For hereditary angioedema (hae), expect:

• MA plan step therapy on Part B drugs
• Skilled nursing facility days
• Prior auth on specialty drugs
• OON emergency reduction

Treatments most often denied in this category

These are the hereditary angioedema (hae) treatments most often flagged for prior auth, step therapy, or medical necessity review:

• Takhzyro
• Orladeyo
• Haegarda
• Cinryze
• Berinert
• Ruconest

How to submit the appeal to Humana

1. Read the denial letter — note the exact denial reason code and the appeal deadline (60 days from the date on the letter).
2. Gather supporting documentation: physician letter of medical necessity, relevant clinical notes, peer-reviewed citations supporting the treatment for your indication, and the policy or coverage document Humana cited in the denial.
3. File the appeal through Humana's portal (members: https://www.humana.com ; providers: https://www.humana.com/provider). Standard decision returns within 30 days; expedited urgent appeals return within 72 hours.
4. If denied again, request external review by an independent reviewer within 4 months of the final internal denial. In KY, the state insurance department coordinates external review for fully-insured plans; ERISA self-funded plans use a federal external review through DOL/EBSA.

Clinician or prior-auth team handling this on the practice side? See Humana's prior-authorization criteria by drug: Humana PA criteria on ApprovalHelp.